Header graphic for print
LimeGreenIP News

Tag Archives: Eli Lilly

Hogan Lovells named MIP Global Firm of the Year

London, 9 March 2018 – Hogan Lovells global IP practice has been awarded the accolade of ‘Global IP Firm of the Year’ at the Managing Intellectual Property EMEA awards, in recognition of its market leading and innovative work on matters across Europe and beyond. The firm was shortlisted in 16 categories, also winning awards for:

IPMT Partner Featured in The Lawyer’s Hot 100 2018

Daniel Brook, partner in our London office has been included in the recently-published The Lawyer’s Hot 100 list. The prestigious list from leading UK legal magazine The Lawyer celebrates the most daring, innovative and creative lawyers in the UK from private practice, in-house and the Bar. Daniel is a patent litigator in the UK and was

UK Supreme Court hands down landmark ruling in favour of Eli Lilly

Following last Friday’s (7 July 2017) unusual move of advance publication of the outcome of the case, the UK Supreme Court now published the reasons for its decision in the long-running Actavis v Eli Lilly case. The reasons show that the UKSC found for Lilly under every point being considered. The result is that Actavis’ products

Hogan Lovells Successfully Acts for Eli Lilly in UK Supreme Court Patent Ruling

In an unusual move, the UK Supreme Court (UKSC) has given its key conclusions in the long running Actavis v Eli Lilly case ahead of giving the full judgment. The UKSC allowed Eli Lilly’s appeal and held that Actavis’ products directly infringe Lilly’s patent in the United Kingdom, France, Italy and Spain. The full judgment